$2.68T
Total marketcap
$45.9B
Total volume
BTC 49.89%     ETH 17.07%
Dominance

Xeno Transplants XENO Stock

0.0001 USD {{ price }} 0.000000% {{change_pct}}%
Market Cap
64.58K USD
LOW - HIGH [24H]
0.0001 - 0.0001 USD
VOLUME [24H]
15K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Xeno Transplants Price Chart

Xeno Transplants XENO Financial and Trading Overview

Xeno Transplants stock price 0.0001 USD
Previous Close 0.0001 USD
Open 0.0001 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0001 - 0.0001 USD
52 Week Range 0.0001 - 0.0002 USD
Volume 30K USD
Avg. Volume 627 USD
Market Cap 64.58K USD
Beta (5Y Monthly) -22.432394
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

XENO Valuation Measures

Enterprise Value 506.01K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.099999994
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Xeno Transplants Stock Price History

Beta (5Y Monthly) -22.432394
52-Week Change -50.00000000000000000000000000000000%
S&P500 52-Week Change 20.43%
52 Week High 0.0002 USD
52 Week Low 0.0001 USD
50-Day Moving Average 0.0001 USD
200-Day Moving Average 0.0001435 USD

XENO Share Statistics

Avg. Volume (3 month) 627 USD
Avg. Daily Volume (10-Days) 3K USD
Shares Outstanding 0
Float N/A
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 2.5:1

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2007
Most Recent Quarter (mrq) March 31, 2008
Next Fiscal Year End June 30, 2008

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -256370 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 261 USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 502.23K USD
Total Debt/Equity (mrq) 1509.2 USD
Current Ratio (mrq) 0.148
Book Value Per Share (mrq) 0.001

Cash Flow Statement

Operating Cash Flow (ttm) -258062 USD
Levered Free Cash Flow (ttm) N/A

Profile of Xeno Transplants

Country United States
State MA
City Brookline
Address 143 Gardner Road
ZIP 02445
Phone 617-566-5228
Website N/A
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.

Q&A For Xeno Transplants Stock

What is a current XENO stock price?

Xeno Transplants XENO stock price today per share is 0.0001 USD.

How to purchase Xeno Transplants stock?

You can buy XENO shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Xeno Transplants?

The stock symbol or ticker of Xeno Transplants is XENO.

Which industry does the Xeno Transplants company belong to?

The Xeno Transplants industry is Biotechnology.

How many shares does Xeno Transplants have in circulation?

The max supply of Xeno Transplants shares is 645.82M.

What is Xeno Transplants Price to Earnings Ratio (PE Ratio)?

Xeno Transplants PE Ratio is now.

What was Xeno Transplants earnings per share over the trailing 12 months (TTM)?

Xeno Transplants EPS is 0 USD over the trailing 12 months.

Which sector does the Xeno Transplants company belong to?

The Xeno Transplants sector is Healthcare.